ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer.
Sato T, Saito M, Nakajima S, Saito K, Katagata M, Fukai S, Okayama H, Sakamoto W, Saze Z, Momma T, Mimura K, Kono K.
Sato T, et al. Among authors: fukai s.
Gastric Cancer. 2023 May;26(3):379-392. doi: 10.1007/s10120-023-01373-6. Epub 2023 Feb 22.
Gastric Cancer. 2023.
PMID: 36811690